The Influenza A (H1N1) vaccine has been proven to generate an immune response in a high percentage of adults in clinical trials. By May 2010, Sanofi had produced 87 million doses of the Influenza A (H1N1) vaccine for the US Government.
-
Sanofi Pasteur's vaccine against Influenza A (H1N1) was approved in September... -
The Influenza A (H1N1) vaccine has been proven to generate an immune response... -
The Influenza A (H1N1) 2009 Monovalent Vaccine contains an inactivated...
